Error loading player: No playable sources found
Pandemic’s Impact for Supply Chain
Date
January 26, 2022
This product is not available for individual purchase, but it is available as part of the following products:
Supply of raw materials has been a risk to the biomanufacturing industry for many years, however, the pandemic has worsened and accelerated what is now no longer a risk but a reality.
The session will explore how industry and the regulators are mitigating risks for the current and future state of the raw material supply chain; three perspectives will be shared, that of suppliers, end users and regulators.
Session Speakers:
10:45 - 11:10
Managing Raw Material Supply Chain Challenges during the COVID-19 Pandemic and Resulting Future Opportunities - A Roche Perspective
V Stefan Paschen, Roche Diagnostics GmbH
11:10 - 11:35
Supplying an mRNA COVID 19 Vaccine at Unprecedented Pace and Scale
V David Sullivan, Pfizer, Inc.
11:35 - 12:00
Regulatory Approaches to Manage Supply Chain Challenges
V Patricia Hughes, CDER, FDA
12:00 - 12:15
Discussion - Questions and Answers
The session will explore how industry and the regulators are mitigating risks for the current and future state of the raw material supply chain; three perspectives will be shared, that of suppliers, end users and regulators.
Session Speakers:
10:45 - 11:10
Managing Raw Material Supply Chain Challenges during the COVID-19 Pandemic and Resulting Future Opportunities - A Roche Perspective
V Stefan Paschen, Roche Diagnostics GmbH
11:10 - 11:35
Supplying an mRNA COVID 19 Vaccine at Unprecedented Pace and Scale
V David Sullivan, Pfizer, Inc.
11:35 - 12:00
Regulatory Approaches to Manage Supply Chain Challenges
V Patricia Hughes, CDER, FDA
12:00 - 12:15
Discussion - Questions and Answers
Session Chairs
Speakers
CDER, FDA
General
Tracks
Related Products
“Alone We Can Do So Little, Together We Can Do So Much” - How Did 25 Years of WCBP Conferences Shape Our Thinking and Our Way of Working?
“Alone we can do so little, together we can do so much” is a Helen Keller quote which captures the spirit of CASSS-organized conferences like WCBP, the regional CMC strategy forums, and technology specific meetings…
We Share Our Planet - Options to Remove Animals and/or Animal- derived Reagents from Release Testing
Use of animals and/or animal derived products to demonstrate safety or efficacy supports drug development and, in some cases, is required by law to release drug product…
Accelerating Vaccine Development Through Technology Platforms
Industry and regulatory authorities speed of response to the COVID-19 pandemic crisis demonstrated the capability to develop new therapeutics in the face of a dire situation…
